Características, beneficio clínico y financiación de las nuevas autorizaciones de fármacos oncohematológicos en España entre 2017 y 2020 Martinez-Barros; Álvaro Pousada-Fonseca; Jorge Pedreira-Bouzas; Clopes-Estela;

[Translated article] Characteristics, clinical benefit, and reimbursement of new authorisations for oncohaematology drugs in Spain between 2017 and 2020 Martinez-Barros; Álvaro Pousada-Fonseca; Jorge Pedreira-Bouzas; Clopes-Estela;

Concordance between expectations and preferences of patients and evaluation criteria of the European Medicines Agency Manuel David Gil-Sierra; María del Pilar Briceño-Casado; Ángel Jesús Arias-Arias; Santiago Martín-Rodríguez;